EpiBone, Inc.

📍 Brooklyn, United States🗓 Founded 2013👥 21 employees💰 Last funded Jun 2020
Biotechnology Research🌐 epibone.com
Website LinkedIn
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.
3
Total investors
1
Early stage
0
Mid stage
2
Late stage
2013
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Investor activity2015–2020 · investors recorded per year
201512019120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in EpiBone, Inc.?
EpiBone, Inc. has 3 investors on record on gritt.io, including 1 early-stage backers and 2 late-stage investors.
When did EpiBone, Inc. last raise funding?
The most recent investment in EpiBone, Inc. recorded on gritt.io was in June 2020.
When was EpiBone, Inc. founded?
EpiBone, Inc. was founded in 2013.
What industry is EpiBone, Inc. in?
EpiBone, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is EpiBone, Inc. based?
EpiBone, Inc. is headquartered in Brooklyn, United States.